We are live on ! Find out more
DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of DMAQR yet.

DMAQR Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q1 2024, worth a combined $0 — down 100% from $1.85M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of DMAQR and 0 opened new positions — a net loss of 24 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Highbridge Capital Management, exiting entirely with an estimated $229K sold.

  • 0 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q1 2024, down from 24 in Q4 2023.
  • Funds reported $0 of Deep Medicine Acquisition Corp. Rights stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Deep Medicine Acquisition Corp. Rights positions in Q1 2024 and 24 closed out, a net change of -24 holders.
  • The largest Deep Medicine Acquisition Corp. Rights seller in Q1 2024 was Highbridge Capital Management, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2024.